Di-n-butyl phthalate modifies PMA-induced macrophage differentiation of THP-1 monocytes via PPARγ.

[1]  J. Holme,et al.  Decreased macrophage phagocytic function due to xenobiotic exposures in vitro, difference in sensitivity between various macrophage models. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[2]  N. Kamimura,et al.  Phthalates impact human health: Epidemiological evidences and plausible mechanism of action. , 2017, Journal of hazardous materials.

[3]  Hong-ying Yu,et al.  Phenotypic switch in lung interstitial macrophage polarization in an ovalbumin-induced mouse model of asthma , 2017, Experimental and therapeutic medicine.

[4]  J. Yoon,et al.  Structural basis for differential activities of enantiomeric PPARγ agonists: Binding of S35 to the alternate site. , 2017, Biochimica et biophysica acta. Proteins and proteomics.

[5]  T. Nawrot,et al.  Phthalate-induced oxidative stress and association with asthma-related airway inflammation in adolescents. , 2017, International journal of hygiene and environmental health.

[6]  D. Kojetin,et al.  Modification of the Orthosteric PPARγ Covalent Antagonist Scaffold Yields an Improved Dual-Site Allosteric Inhibitor. , 2017, ACS chemical biology.

[7]  C. Calhau,et al.  Effects of xenoestrogens in human M1 and M2 macrophage migration, cytokine release, and estrogen‐related signaling pathways , 2016, Environmental toxicology.

[8]  M. Woo,et al.  Cell Surface CD36 Protein in Monocyte/Macrophage Contributes to Phagocytosis during the Resolution Phase of Ischemic Stroke in Mice* , 2016, The Journal of Biological Chemistry.

[9]  S. Wise,et al.  Epidemiology and economic burden of asthma , 2015, International forum of allergy & rhinology.

[10]  Heather M Stapleton,et al.  Activation of Human Peroxisome Proliferator-Activated Nuclear Receptors (PPARγ1) by Semi-Volatile Compounds (SVOCs) and Chemical Mixtures in Indoor Dust. , 2015, Environmental science & technology.

[11]  M. D’Innocenzo,et al.  Effects of Endocrine Disruptor Compounds, Alone or in Combination, on Human Macrophage-Like THP-1 Cell Response , 2015, PloS one.

[12]  Young In Park,et al.  Estrogenic Endocrine-Disrupting Chemicals Modulate the Production of Inflammatory Mediators and Cell Viability of Lipopolysaccharide-Stimulated Macrophages , 2015, Inflammation.

[13]  G. Clausen,et al.  Phthalate exposure through different pathways and allergic sensitization in preschool children with asthma, allergic rhinoconjunctivitis and atopic dermatitis. , 2015, Environmental research.

[14]  Frederica P. Perera,et al.  Asthma in Inner-City Children at 5–11 Years of Age and Prenatal Exposure to Phthalates: The Columbia Center for Children’s Environmental Health Cohort , 2014, Environmental health perspectives.

[15]  Maxim N. Artyomov,et al.  Cell-intrinsic lysosomal lipolysis is essential for macrophage alternative activation , 2014, Nature Immunology.

[16]  Young Mi Park.  CD36, a scavenger receptor implicated in atherosclerosis , 2014, Experimental & Molecular Medicine.

[17]  C. Bornehag,et al.  PVC flooring at home and development of asthma among young children in Sweden, a 10-year follow-up. , 2014, Indoor air.

[18]  J. Balsinde,et al.  Critical Role of TLR2 and MyD88 for Functional Response of Macrophages to a Group IIA-Secreted Phospholipase A2 from Snake Venom , 2014, PloS one.

[19]  Travis S. Hughes,et al.  An alternate binding site for PPARγ ligands , 2014, Nature Communications.

[20]  A. Rudich,et al.  FABP4 Attenuates PPARγ and Adipogenesis and Is Inversely Correlated With PPARγ in Adipose Tissues , 2014, Diabetes.

[21]  A. Sakhi,et al.  Pulmonary phthalate exposure and asthma - is PPAR a plausible mechanistic link? , 2013, EXCLI journal.

[22]  Y. Ahn,et al.  Modulation of the Transcriptional Activity of Peroxisome Proliferator-Activated Receptor Gamma by Protein-Protein Interactions and Post-Translational Modifications , 2013, Yonsei medical journal.

[23]  Haishan Li,et al.  The immunotoxicity of dibutyl phthalate on the macrophages in mice , 2013, Immunopharmacology and immunotoxicology.

[24]  Hong Ma,et al.  Biological impact of phthalates. , 2013, Toxicology letters.

[25]  A. Calafat,et al.  Urinary Biomarkers for Phthalates Associated with Asthma in Norwegian Children , 2012, Environmental health perspectives.

[26]  Angus I. Lamond,et al.  Dynamic Proteomics: Methodologies and Analysis , 2012 .

[27]  Jamey D. Young,et al.  PPARγ isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation , 2012, Cell Death and Disease.

[28]  B. Chain,et al.  Adherent Human Alveolar Macrophages Exhibit a Transient Pro-Inflammatory Profile That Confounds Responses to Innate Immune Stimulation , 2012, PloS one.

[29]  Yi Cheng Li,et al.  Predicted risk of childhood allergy, asthma, and reported symptoms using measured phthalate exposure in dust and urine. , 2012, Indoor air.

[30]  J. Holme,et al.  Mono-2-ethylhexylphthalate (MEHP) induces TNF-α release and macrophage differentiation through different signalling pathways in RAW264.7 cells. , 2012, Toxicology letters.

[31]  Jisu Oh,et al.  Endoplasmic Reticulum Stress Controls M2 Macrophage Differentiation and Foam Cell Formation* , 2012, The Journal of Biological Chemistry.

[32]  M. J. Chalmers,et al.  Ligand and receptor dynamics contribute to the mechanism of graded PPARγ agonism. , 2012, Structure.

[33]  T. Wynn,et al.  Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.

[34]  M. Febbraio,et al.  The emerging roles of fatty acid translocase/CD36 and the aryl hydrocarbon receptor in fatty liver disease , 2011, Experimental biology and medicine.

[35]  D. Postma,et al.  More alternative activation of macrophages in lungs of asthmatic patients. , 2011, The Journal of allergy and clinical immunology.

[36]  K. Morikawa,et al.  The nuclear receptor PPARγ individually responds to serotonin‐ and fatty acid‐metabolites , 2010, The EMBO journal.

[37]  Wei Wu,et al.  Comparison of in vitro hormone activities of selected phthalates using reporter gene assays. , 2009, Toxicology letters.

[38]  Eva Cecilie Bonefeld-Jorgensen,et al.  Effects of plasticizers and their mixtures on estrogen receptor and thyroid hormone functions. , 2009, Toxicology letters.

[39]  Béatrice Desvergne,et al.  PPAR-mediated activity of phthalates: A link to the obesity epidemic? , 2009, Molecular and Cellular Endocrinology.

[40]  K. Morikawa,et al.  Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids. , 2009, Journal of molecular biology.

[41]  K. Hashizume,et al.  Effects of phthalate ester derivatives including oxidized metabolites on coactivator recruiting by PPARalpha and PPARgamma. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[42]  J. Schwabe,et al.  Structural basis for the activation of PPARγ by oxidized fatty acids , 2008, Nature Structural &Molecular Biology.

[43]  Tanja Krüger,et al.  Plastic components affect the activation of the aryl hydrocarbon and the androgen receptor. , 2008, Toxicology.

[44]  Scott A. Busby,et al.  Partial agonists activate PPARgamma using a helix 12 independent mechanism. , 2007, Structure.

[45]  S. Haulon,et al.  PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. , 2007, Cell metabolism.

[46]  Frank Brombacher,et al.  Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.

[47]  M. Kowalski,et al.  Endocrine disrupters – potential modulators of the immune system and allergic response , 2006, Allergy.

[48]  N. Frossard,et al.  Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? , 2006, Fundamental & clinical pharmacology.

[49]  D. Strachan,et al.  Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys , 2006, The Lancet.

[50]  K. Hungerbühler,et al.  What Are the Sources of Exposure to Eight Frequently Used Phthalic Acid Esters in Europeans? , 2006, Risk analysis : an official publication of the Society for Risk Analysis.

[51]  T. Osumi,et al.  Aspects of the regulatory mechanisms of PPAR functions: Analysis of a bidirectional response element and regulation by sumoylation , 2006, Molecular and Cellular Biochemistry.

[52]  Béatrice Desvergne,et al.  From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. , 2006, Progress in lipid research.

[53]  N. Åberg,et al.  'Dampness' at home and its association with airway, nose, and skin symptoms among 10,851 preschool children in Sweden: a cross-sectional study. , 2005, Indoor air.

[54]  M. Iida,et al.  Differential effects of phthalate esters on transcriptional activities via human estrogen receptors α and β, and androgen receptor , 2005 .

[55]  N. Kamiya,et al.  α,β-Unsaturated Ketone Is a Core Moiety of Natural Ligands for Covalent Binding to Peroxisome Proliferator-activated Receptor γ* , 2005, Journal of Biological Chemistry.

[56]  Charles J. Weschler,et al.  The Association between Asthma and Allergic Symptoms in Children and Phthalates in House Dust: A Nested Case–Control Study , 2004, Environmental health perspectives.

[57]  A. C. Nicholson,et al.  CD36, oxidized LDL and PPARγ: pathological interactions in macrophages and atherosclerosis , 2004 .

[58]  J. Auwerx,et al.  Adipose tissue expression of the lipid droplet-associating proteins S3-12 and perilipin is controlled by peroxisome proliferator-activated receptor-gamma. , 2004, Diabetes.

[59]  Yayun Liang,et al.  Estradiol down-regulates CD36 expression in human breast cancer cells. , 2004, Cancer letters.

[60]  John D Spengler,et al.  Asthma, wheezing, and allergies in Russian schoolchildren in relation to new surface materials in the home. , 2004, American journal of public health.

[61]  S. London,et al.  Phthalate exposure and pulmonary function. , 2004, Environmental health perspectives.

[62]  T. Tsukamoto,et al.  Tissue-Selective, Bidirectional Regulation of PEX11α and Perilipin Genes through a Common Peroxisome Proliferator Response Element , 2004, Molecular and Cellular Biology.

[63]  K. Chida,et al.  Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages. , 2004, American journal of respiratory and critical care medicine.

[64]  T. Willson,et al.  Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. , 2002, Biochemistry.

[65]  B. Staels,et al.  Peroxisome proliferator‐activated receptor (PPAR) agonists decrease lipoprotein lipase secretion and glycated LDL uptake by human macrophages , 2002, FEBS letters.

[66]  R. Silverstein,et al.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. , 2001, The Journal of clinical investigation.

[67]  J. Jaakkola,et al.  Plastic wall materials in the home and respiratory health in young children. , 2000, American journal of public health.

[68]  K. Umesono,et al.  A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.

[69]  V. Fadok,et al.  CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). , 1998, Journal of immunology.

[70]  V. Fadok,et al.  CD36 Is Required for Phagocytosis of Apoptotic Cells by Human Macrophages That Use Either a Phosphatidylserine Receptor or the Vitronectin Receptor (αvβ3) , 1998, The Journal of Immunology.

[71]  T. Willson,et al.  Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ , 1998, Nature.

[72]  R. Evans,et al.  PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.

[73]  W. Wahli,et al.  Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. , 1997, Molecular endocrinology.

[74]  Y. Surh,et al.  Docosahexaenoic acid induces M2 macrophage polarization through peroxisome proliferator-activated receptor γ activation. , 2015, Life sciences.

[75]  G. Pereira.  Distinct Macrophage Phenotypes in Allergic and Nonallergic Lung Inflammation , 2015 .

[76]  S. Croisant.  Epidemiology of asthma: prevalence and burden of disease. , 2014, Advances in experimental medicine and biology.

[77]  A. Ray,et al.  Macrophages: regulators of sex differences in asthma? , 2010, American journal of respiratory cell and molecular biology.

[78]  J. Schwabe,et al.  Structural Basis for the Activation of Pparg by Oxidised Fatty Acids , 2008 .

[79]  V. Keshamouni,et al.  Peroxisome Proliferator-activated Receptor-γ as a Regulator of Lung Inflammation and Repair , 2005 .